SANIMED
ActiveSANIMED has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €619k and a net result of €29k. Equity is shrinking by ~8.3% per year across the filed fiscal years. Its solvency ranks better than 88% of 10230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
94
/ 100
Excellent▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability23▲+16
Solvency100=
Growth32=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 3.57 against 3.1 in 2024), and 21.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
78.8%
Return on assets
3.7%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
80 d early
2024
45 d early
2023
50 d early
2022
52 d early
2021
54 d early
2020
47 d early
2019
24 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€619k▲ 4.9%
2024 · €590k
2018: €1.35M
2019: €1.42M
2020: €1.48M
2021: €1.55M
2022: €1.64M
2023: €582k
2024: €590k
2018 → 2025
Total assets
€786k▲ 2.1%
2024 · €770k
2018: €1.51M
2019: €1.57M
2020: €1.65M
2021: €1.72M
2022: €1.84M
2023: €761k
2024: €770k
2018 → 2025
Net result
€29k▲ 249%
2024 · €8k
2018: €116k
2019: €71k
2020: €59k
2021: €71k
2022: €96k
2023: €35k
2024: €8k
2018 → 2025
Working capital
€429k▲ 13.5%
2024 · €378k
2018: €1.27M
2019: €1.35M
2020: €1.42M
2021: €1.49M
2022: €1.42M
2023: €342k
2024: €378k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.55M-€1.64M▲ 6.2%€582k▼ 64.6%€590k▲ 1.4%€619k▲ 4.9%
Operating result€103k-€109k▲ 5.6%€40k▼ 63.6%€4k▼ 89.4%€32k▲ 670%
Net result€71k-€96k▲ 35.5%€35k▼ 63.2%€8k▼ 76.4%€29k▲ 249%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 670% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €786k
Fixed assets
€191k▼ 10.3%
Current assets
€596k▲ 6.8%
Equity and liabilities €786k
Equity
€619k▲ 4.9%
Debt
€167k▼ 7.3%
The debt ratio falls from 23.4% to 21.2%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€62k▲
2024 · €33k
Cash flow
€59k▲
2024 · €37k
Solvency
78.8%▲
2024 · 76.6%
Current ratio
3.57▲
2024 · 3.10
Quick ratio
2.74▲
2024 · 2.32
Debt / equity
0.27▼
2024 · 0.30
ROE
4.7%▲
2024 · 1.4%
ROA
3.7%▲
2024 · 1.1%
Interest coverage
118.75▲
2024 · 74.73
Debt
€167k▼
2024 · €180k
Debt ≤ 1 year
€167k▼
2024 · €180k
Income taxes
€12k▲
2024 · €5k
Staff costs
€231k▼
2024 · €236k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€770k€786k▲
Formation expenses20€0€0=
Fixed assets21/28€213k€191k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€213k€191k▼
Land and buildings22€69k€62k▼
Plant, machinery and equipment23€138k€122k▼
Furniture and vehicles24€6k€7k▲
Current assets29/58€558k€596k▲
Stocks and contracts in progress3€140k€138k▼
Stocks30/36€140k€138k▼
Amounts receivable within one year40/41€408k€449k▲
Trade receivables40€117k€122k▲
Other amounts receivable41€291k€327k▲
Cash at bank and in hand54/58€10k€9k▼
Equity and liabilities
Total equity and liabilities10/49€770k€786k▲
Equity10/15€590k€619k▲
Contributions10/11€19k€19k=
Reserves13€572k€601k▲
Distributable reserves133€572k€601k▲
Amounts payable17/49€180k€167k▼
Amounts payable within one year42/48€180k€167k▼
Trade debts44€152k€140k▼
Suppliers440/4€152k€140k▼
Taxes, remuneration and social security45€28k€27k▼
Taxes450/3-€2k
Remuneration and social security454/9€28k€26k▼
Income statement
Code20242025
Non-recurring operating income76A€3k-
Remuneration, social security and pensions62€236k€231k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€28k€30k▲
Other operating charges640/8€3k€3k▼
Gross operating margin9900€271k€295k▲
Operating profit (loss)9901€4k€32k▲
Financial income75/76B€9k€9k▼
Recurring financial income75€9k€9k▼
Financial charges65/66B€437€523▲
Recurring financial charges65€437€523▲
Profit (loss) for the period before taxes9903€13k€41k▲
Income taxes67/77€5k€12k▲
Profit (loss) for the period9904€8k€29k▲
Profit (loss) for the period to be appropriated9905€8k€29k▲
Appropriation of the result
Profit (loss) to be appropriated9906€8k€29k▲
Transfer to equity691/2€8k€29k▲
To other reserves6921€8k€29k▲
Social balance
Average headcount (FTE)90874.03.2▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
16-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Weakest financial yearnet €8k ▼76.4%
Net result drops to €8k, the lowest in the series; recovery starts the following year.
11-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
09-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
07-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
14-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
07-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
09-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
28-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
10-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 directors, no change since 2022
Alexo BV
CurrentDirector · since 01-09-2022 · Legal entity
01-12-2022
Tom Goderis: Appointed as Permanent representative
01-09-2022
Alexo BV: Appointed as Director
01-09-2022
Alexo BV: Appointed as Chair
01-09-2022
Olivier Delaere: Appointed as Permanent representative
31-08-2022
Aristo BV: Resigned as Director
31-08-2022
Frank Coene: Appointed as Permanent representative
Location & real-estate footprint
Registered office, Oudenburg · 1 establishment unit since 1993
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Dorpsstraat 998460 OudenburgGround area
847 m²
Building footprint
230 m²
Volume, LiDAR
887 m³
Parcel 35004C0460/00D000, Flanders · tallest building 6.0 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
SANIMED
since 19932.062.435.873
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 35004C0460/00D000 | Flanders | 847 m² | 1 · 230 m² | 6.0 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteOudenburg2.062.435.873
Similar companies · same sector, comparable size
APOTHEEK HECHTEL
BE 0791.683.712
Hechtel-Eksel · Eq €619k
MOERMAN ANN
BE 0808.468.175
Knokke-Heist · Eq €619k
MENDELJEV
BE 0830.138.866
Beernem · Eq €620k
Pharma Invest Devos
BE 0899.883.252
Halle · Eq €618k
APOTHEKER STEVEN VRIJDAG
BE 0817.319.624
Dendermonde · Eq €618k
Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,265 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-11-1992
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 33 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.